# Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

> **NCT00133159** · PHASE2 · COMPLETED · sponsor: **Allergy Therapeutics** · enrollment: 68 (—)

## Conditions studied

- Type I Hypersensitivity

## Interventions

- **BIOLOGICAL:** Grass MATAMPL

## Key facts

- **NCT ID:** NCT00133159
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-12
- **Primary completion:** 2005-11-08
- **Final completion:** 2005-11-08
- **Target enrollment:** 68 (—)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133159, "Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00133159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*